Name
Kiviõli Linnaapteegi Osaühing
Registry code
10032550
VAT number
EE100660748
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.05.1996 (28)
Financial year
01.01-31.12
Capital
2 550.00 €
Activity
21201 - Manufacture of pharmaceutical preparations 47731 - Dispensing chemist in specialised stores
1 413 468 €
12 368 €
1%
3 960 €
(estimate is approximate)
19 108 €
3
Submitted
No tax arrears
65%
8%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Anu Nõlvak 19.11.1961 (63) | 16% - 408.00 EUR | - | Direct ownership | Founder |
| Ingrit Haavistu 04.11.1948 (76) | 16% - 408.00 EUR | - | Direct ownership | Founder |
| Vilve Molotov 24.09.1951 (73) | 16% - 408.00 EUR | - | Direct ownership | Founder |
| Pille Kabel 11.12.1960 (64) | 52% - 1 326.00 EUR | Board member | Direct ownership | Founder |
| Anne-Liis Raudsepp 16.08.1943 (81) | - | - | - | Founder |
| 2019 22.06.2020 | 2020 28.06.2021 | 2021 21.03.2022 | 2022 07.02.2023 | 2023 24.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 1 174 412 € | 1 278 325 € | 1 180 154 € | 1 280 395 € | 1 413 468 € |
| Net profit (loss) for the period | 5 834 € | 15 755 € | 8 916 € | 11 072 € | 12 368 € |
| Profit Margin | 0% | 1% | 1% | 1% | 1% |
| Current Assets | 162 872 € | 122 326 € | 127 382 € | 131 646 € | 153 672 € |
| Fixed Assets | 0 € | 21 900 € | 17 859 € | 14 603 € | 9 875 € |
| Total Assets | 162 872 € | 144 226 € | 145 241 € | 146 249 € | 163 547 € |
| Current Liabilities | 143 874 € | 121 473 € | 125 572 € | 127 508 € | 144 439 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 18 998 € | 22 753 € | 19 669 € | 18 741 € | 19 108 € |
| Employees | 4 | 3 | 2 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 380 636.57 € | 26 325.14 € | 18 169.54 € | 3 |
| 2023 Q4 | 396 231.33 € | 27 877.65 € | 21 531.12 € | 3 |
| 2023 Q3 | 350 028.33 € | 23 586.87 € | 18 851.89 € | 3 |
| 2023 Q2 | 352 589.98 € | 19 494.23 € | 11 995.09 € | 3 |
| 2023 Q1 | 326 094.79 € | 23 178.2 € | 17 150.82 € | 3 |
| 2022 Q4 | 341 773.77 € | 22 770.16 € | 17 643.36 € | 3 |
| 2022 Q3 | 315 573.97 € | 20 596.73 € | 16 341.96 € | 3 |
| 2022 Q2 | 319 902.65 € | 22 213.46 € | 14 107.95 € | 3 |
| 2022 Q1 | 327 127.5 € | 22 094.03 € | 16 734.55 € | 3 |
| 2021 Q4 | 321 869.36 € | 20 155.7 € | 15 291.3 € | 3 |
| 2021 Q3 | 303 158.47 € | 21 548.47 € | 17 157.96 € | 3 |
| 2021 Q2 | 302 234.37 € | 19 837.41 € | 12 091.76 € | 3 |
| 2021 Q1 | 275 308.68 € | 18 726.17 € | 15 881.25 € | 3 |
| 2020 Q4 | 333 855.14 € | 21 093.86 € | 16 507.63 € | 3 |
| 2020 Q3 | 289 840.07 € | 20 100.36 € | 16 563.79 € | 3 |
| 2020 Q2 | 353 220.33 € | 25 244.7 € | 16 664.78 € | 3 |
| 2020 Q1 | 347 607.12 € | 18 615.09 € | 14 340.52 € | 3 |
